JP2017057207A5 - - Google Patents

Download PDF

Info

Publication number
JP2017057207A5
JP2017057207A5 JP2016224622A JP2016224622A JP2017057207A5 JP 2017057207 A5 JP2017057207 A5 JP 2017057207A5 JP 2016224622 A JP2016224622 A JP 2016224622A JP 2016224622 A JP2016224622 A JP 2016224622A JP 2017057207 A5 JP2017057207 A5 JP 2017057207A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
alkylaminoalkyl
general formula
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016224622A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017057207A (ja
JP6242464B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017057207A publication Critical patent/JP2017057207A/ja
Publication of JP2017057207A5 publication Critical patent/JP2017057207A5/ja
Application granted granted Critical
Publication of JP6242464B2 publication Critical patent/JP6242464B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016224622A 2012-04-27 2016-11-18 トランス−2−デセン酸誘導体及びこれを含有する医薬 Expired - Fee Related JP6242464B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012103306 2012-04-27
JP2012103306 2012-04-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014512706A Division JP6047152B2 (ja) 2012-04-27 2013-04-26 トランス−2−デセン酸誘導体及びこれを含有する医薬

Publications (3)

Publication Number Publication Date
JP2017057207A JP2017057207A (ja) 2017-03-23
JP2017057207A5 true JP2017057207A5 (enExample) 2017-04-27
JP6242464B2 JP6242464B2 (ja) 2017-12-06

Family

ID=49483290

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014512706A Active JP6047152B2 (ja) 2012-04-27 2013-04-26 トランス−2−デセン酸誘導体及びこれを含有する医薬
JP2016224622A Expired - Fee Related JP6242464B2 (ja) 2012-04-27 2016-11-18 トランス−2−デセン酸誘導体及びこれを含有する医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014512706A Active JP6047152B2 (ja) 2012-04-27 2013-04-26 トランス−2−デセン酸誘導体及びこれを含有する医薬

Country Status (14)

Country Link
US (1) US9428477B2 (enExample)
EP (1) EP2842942B1 (enExample)
JP (2) JP6047152B2 (enExample)
KR (1) KR20150013143A (enExample)
CN (1) CN104254521B (enExample)
AU (1) AU2013253408C1 (enExample)
BR (1) BR112014026535A2 (enExample)
CA (1) CA2870822C (enExample)
ES (1) ES2618297T3 (enExample)
IL (1) IL235267A (enExample)
RU (1) RU2602810C2 (enExample)
SG (1) SG11201406942SA (enExample)
TW (1) TWI636975B (enExample)
WO (1) WO2013161993A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6086890B2 (ja) * 2013-10-25 2017-03-01 日本臓器製薬株式会社 トランス−2−デセン酸誘導体を含有する医薬
CN106659704B (zh) 2014-06-06 2020-03-10 迪肯大学 治疗孤独症谱系障碍的药物和用途
CA3079819C (en) * 2017-11-06 2023-03-14 Acelot, Inc. Small molecule drugs and related methods for treatment of diseases related to a.beta.42 oligomer formation
CN118976017A (zh) * 2024-08-02 2024-11-19 南京邮电大学 中碳链烯酸及其衍生物在制备促进血管再生和神经功能恢复药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294794A (en) 1963-12-19 1966-12-27 Raiford L Holmes 4-(2-alkenoyl, or 2 bromoalkanoyl) morpholines
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
CA2398923A1 (en) * 2000-02-07 2001-08-16 Zhenhua Yang A group of anti-cancer compounds with specific structure and their production method
US7329767B2 (en) * 2003-10-03 2008-02-12 International Flavors & Fragrances Inc. Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
WO2009038110A1 (ja) 2007-09-19 2009-03-26 Nagoya Industrial Science Research Institute 神経栄養因子様作用剤
US9414590B2 (en) * 2009-03-16 2016-08-16 Marrone Bio Innovations, Inc. Chemical and biological agents for the control of molluscs
KR20120026498A (ko) * 2009-04-20 2012-03-19 마론 바이오 이노베이션스, 인코포레이티드 연체 동물 방제용 화학제 및 생물학제
DK2710892T3 (en) * 2009-07-21 2017-03-20 Marrone Bio Innovations Inc Use of sarmentin and analogues thereof for the control of weeds
SI2528598T1 (sl) 2010-01-27 2016-04-29 Takeda Pharmaceutical Company Limited Spojine za supresijo periferne živčne motnje, inducirane s sredstvom proti raku
ES2624845T3 (es) * 2010-09-29 2017-07-17 Intervet International B.V. Compuestos de N-heteroarilo con unidad de puente cíclico para el tratamiento de enfermedades parasitarias
BR112013010709A2 (pt) 2010-11-02 2019-09-24 Nagoya Industrial Science Res Institute derivado de ácido trans-2-decenoico e agente farmacêutico contendo o mesmo

Similar Documents

Publication Publication Date Title
JP2017222697A5 (enExample)
JP2017057207A5 (enExample)
MX2015010837A (es) Compuestos de antranilamida, sus mezclas y el uso de los mismos como pesticidas.
CY1118319T1 (el) Αλατα και πολυμορφα της 8-φθορο-2-{4-[(μεθυλαμινο)μεθυλο]φαινυλο}-1,3,4,5-τετραϋδρο-6η-αζεπινο[5,4,3-cd]ινδολο-6-ονης
EA201790715A1 (ru) Новые соединения
AR092790A1 (es) Derivados bencimidazolicos del acido hidroxamico
PE20141191A1 (es) Compuestos como inhibidores de bace
AR087148A1 (es) Imidazopiridazinas
AR105292A1 (es) Fenoxihalogenofenilamidinas y su uso como fungicidas
PE20171057A1 (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
MX2018009944A (es) Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico.
MX373700B (es) Composicion acuosa novedosa.
SMT201700142T1 (it) SALE DI CAMSILATO DI (1r, 1’R, 4R)-4-METOSSI-5’’-METIL-6’-[5-(PROP-1-IN-1-IL)PIRIDIN-3-IL]-3’H-DISPIRO[CICLOESANO-1,2’-INDEN-1’2’-IMIDAZOLO]-4’’-AMMINA E SUE FORME CRISTALLINE PER IL TRATTAMENTO DI PATOLOGIE A[BETA]-CORRELATE COME PER ESEMPIO LA MALATTIA DI ALZHEIMER
JP2015199738A5 (enExample)
EA201791226A1 (ru) Композиции, содержащие 2-((1-(2-(4-фторфенил)-2-оксоэтил)пиперидин-4-ил)метил)изоиндолин-1-он для лечения шизофрении
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
RU2019131147A (ru) Новые хиназолиноновые производные, ингибирующие pi3k, и содержащая их фармацевтическая композиция
MX2017007574A (es) Composicion.
WO2015068175A3 (en) An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
WO2016135747A3 (en) Process for the preparation of amorphous (1s)-1,5-anhvdro-1-[3-[[5-(4 fluorophennyl)-2-thienyl]methvl]-4-methylphenyl]-d-glucitol and its polymorphs thereof
MX2017007572A (es) Composicion acuosa.
IL264780B (en) A method for producing 2-(3,6-dihalopyridin-2-yl)-3h-imidazolo[4,5-c]pyridine derivatives and similar compounds by reacting a 3h-imidazolo[4,5-c]pyridine derivative with a base Organometallic zinc-amine
MX2016012485A (es) Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
PH12017502010A1 (en) Process for the preparation of 2-{4-[2-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl]phenoxy}ethyl-l-alanyl-l-alaninate monohydrochloride
TR201901449T4 (tr) Yeni bifenil türevi ve bunun hazırlanmasına yönelik yöntem.